Perfil de pacientes con enfermedades minoritarias en Galicia. Perspectiva desde la medicina interna

  1. Alberto Rivera Gallego
  2. Susana Rivera García
  3. Ana Arévalo Gómez
  4. Beatriz Buño Ramilo
  5. Ana María Bravo Blanco 1
  6. Roi Suarez Gil 1
  7. Enrique Chao Villar 2
  8. Álvaro Hermida Ameijeiras
  1. 1 Servicio de Medicina Interna. Xerencia Xestión Integrada área de Lugo, A Mariña y Monforte de Lemos.
  2. 2 CSUR Enfermedades Metabólicas Hereditarias de Santiago de Compostela. Servicio de Medicina Interna. Xerencia Xestión Integrada área de Santiago de Compostela y Barbanza. Área de Medicina. Universidade de Santiago de Compostela.
Journal:
Galicia Clínica
  1. Cardoso, M Teresa

ISSN: 0304-4866 1989-3922

Year of publication: 2021

Volume: 82

Issue: 1

Pages: 9-14

Type: Article

DOI: 10.22546/59/2514 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Galicia Clínica

Abstract

Objectives: Rare diseases (RD) constitute a heterogeneous group of low prevalence conditions, with genetic origin in most cases and frequently associated with a delay in their diagnosis and notable morbidity and mortality. Knowing the clinical profile and the complexity degree of patients with RD who attend internal medicine units in Galicia could facilitate more effective and efficient care settings. Methods: Epidemiological, cross-sectional and multicenter study in patients with low prevalence diseases ≥ 18 years attending the outpatients departments and specific units of internal medicine in Galicia up to December 31, 2020. Data were collected on the number of patients treated regarding their condition at each center, the average age at disease onset, number of comorbidities, number of annual visits to the center and other specialists, number of treatments (including those with a high economic impact), degree of cognitive impairment and assessment of the degree of autonomy. Results: We analyzed data from six participating centers (from six health areas of Galicia), representing a total of 324 patients, with a mean age of 41.3 ±15.8 years. The three main groups of pathologies treated were, in this order, rare genetic diseases, innate errors of metabolism and rare neurological diseases. The mean delay in diagnosis was 4.8 ±7.9 years and 34.17% of patients took 5 or more years to have a diagnostic confirmation. This group with the longest diagnostic delay has a lower score on the Barthel dependency scale and 1.75 times greater use of health resources (consultations with internal medicine and other specialties). 11.75% of the patients present a level of severe or total dependence and 9.9%, a low IQ. Conclusions: Despite their low average age, patients with minority diseases treated in internal medicine services present a high complexity of care derived from the number of comorbidities, visits to consultations, the need for hospital admissions and polypharmacy. Complexity that is closely related to the delay in diagnosis